Mark R. Dowling

3.9k total citations
72 papers, 2.7k citations indexed

About

Mark R. Dowling is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Mark R. Dowling has authored 72 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Immunology and 8 papers in Oncology. Recurrent topics in Mark R. Dowling's work include Receptor Mechanisms and Signaling (13 papers), T-cell and B-cell Immunology (11 papers) and Immune Cell Function and Interaction (10 papers). Mark R. Dowling is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), T-cell and B-cell Immunology (11 papers) and Immune Cell Function and Interaction (10 papers). Mark R. Dowling collaborates with scholars based in Australia, United Kingdom and United States. Mark R. Dowling's co-authors include Andrew C. Doherty, Philip D. Hodgkin, Michael A. Nielsen, Steven J. Charlton, Mile Gu, Edwin D. Hawkins, David A. Sykes, Cameron Wellard, Morten Nielsen and Ken R. Duffy and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Physical Review Letters.

In The Last Decade

Mark R. Dowling

68 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Dowling Australia 29 795 642 527 441 265 72 2.7k
Dominic J. Williamson United States 27 456 0.6× 673 1.0× 767 1.5× 205 0.5× 84 0.3× 64 2.8k
Makoto Katori Japan 33 755 0.9× 258 0.4× 249 0.5× 144 0.3× 199 0.8× 258 3.9k
Charles K. Kaufman United States 21 1.3k 1.6× 243 0.4× 576 1.1× 244 0.6× 143 0.5× 56 2.8k
Shoudan Liang United States 35 3.5k 4.4× 284 0.4× 337 0.6× 153 0.3× 143 0.5× 84 5.5k
Anil Kumar India 35 1.1k 1.4× 351 0.5× 477 0.9× 429 1.0× 30 0.1× 138 4.4k
Gyan Bhanot United States 43 2.8k 3.5× 511 0.8× 410 0.8× 514 1.2× 317 1.2× 162 7.5k
A. S. Majumdar India 26 300 0.4× 136 0.2× 1.3k 2.5× 1.2k 2.8× 232 0.9× 152 2.4k
Stephen A. Ramsey United States 30 2.3k 2.9× 928 1.4× 116 0.2× 75 0.2× 120 0.5× 92 3.9k
David C. Torney United States 24 1.4k 1.7× 116 0.2× 413 0.8× 303 0.7× 136 0.5× 68 2.9k
Иван Тодоров United States 49 2.9k 3.7× 1.2k 1.9× 658 1.2× 58 0.1× 748 2.8× 228 7.8k

Countries citing papers authored by Mark R. Dowling

Since Specialization
Citations

This map shows the geographic impact of Mark R. Dowling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Dowling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Dowling more than expected).

Fields of papers citing papers by Mark R. Dowling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Dowling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Dowling. The network helps show where Mark R. Dowling may publish in the future.

Co-authorship network of co-authors of Mark R. Dowling

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Dowling. A scholar is included among the top collaborators of Mark R. Dowling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Dowling. Mark R. Dowling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sales, Carmela, Izanne Roos, Samantha M. Loi, et al.. (2024). Cognitive and Psychological Recovery from the Immune Effector Cell Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell (CAR-T) Therapy. Blood. 144(Supplement 1). 7240–7240. 1 indexed citations
2.
3.
Robinson, Marcus J, Zhoujie Ding, Mark R. Dowling, et al.. (2023). Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespan. Immunity. 56(7). 1596–1612.e4. 42 indexed citations
4.
Dowling, Mark R., Javad Saghebi, Roxane Legaie, et al.. (2023). Clinical Utility of Circulating Tumor (ct)DNA Quantity and Kinetics in Patients Undergoing CAR T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma. Blood. 142(Supplement 1). 7160–7160. 1 indexed citations
5.
Robinson, Marcus J, Mark R. Dowling, Catherine Pitt, et al.. (2022). Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune response. Science Immunology. 7(76). eabm8389–eabm8389. 33 indexed citations
6.
Dowling, Mark R., David T. Beattie, Michael Faller, et al.. (2020). Development of autotaxin inhibitors: A series of tetrazole cinnamides. Bioorganic & Medicinal Chemistry Letters. 31. 127663–127663. 3 indexed citations
7.
Dowling, Mark R., Cara E. Brocklehurst, Michael Faller, et al.. (2018). Development of autotaxin inhibitors: A series of zinc binding triazoles. Bioorganic & Medicinal Chemistry Letters. 28(13). 2279–2284. 9 indexed citations
8.
Dowling, Mark R., B Dey, Steven L. McAfee, et al.. (2017). Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact. Bone Marrow Transplantation. 53(2). 199–206. 32 indexed citations
9.
Chakravorty, Rajib, David Rawlinson, John Markham, et al.. (2014). Labour-Efficient In Vitro Lymphocyte Population Tracking and Fate Prediction Using Automation and Manual Review. PLoS ONE. 9(1). e83251–e83251. 6 indexed citations
10.
Hodgkin, Philip D., Mark R. Dowling, & Ken R. Duffy. (2014). Why the immune system takes its chances with randomness. Nature reviews. Immunology. 14(10). 711–711. 13 indexed citations
11.
Sykes, David A., Mark R. Dowling, Juliet Leighton-Davies, et al.. (2012). The Influence of Receptor Kinetics on the Onset and Duration of Action and the Therapeutic Index of NVA237 and Tiotropium. Journal of Pharmacology and Experimental Therapeutics. 343(2). 520–528. 92 indexed citations
12.
Mistry, Rajendra, Mark R. Dowling, & R. A. John Challiss. (2011). [35S]GTPγS Binding as an Index of Total G-Protein and Gα-Subtype-Specific Activation by GPCRs. Methods in molecular biology. 746. 263–275. 3 indexed citations
13.
Charlton, Steven J., et al.. (2011). The in vitro metabolism of sphingosine-1-phosphate: Identification; inhibition and pharmacological implications. European Journal of Pharmacology. 672(1-3). 56–61. 3 indexed citations
14.
Dowling, Mark R. & Philip D. Hodgkin. (2009). Why does the thymus involute? A selection-based hypothesis. Trends in Immunology. 30(7). 295–300. 37 indexed citations
15.
Dowling, Mark R. & Michael A. Nielsen. (2008). The geometry of quantum computation. Quantum Information and Computation. 8(10). 861–899. 65 indexed citations
16.
Battram, Cliff H., Steven J. Charlton, Bernard Cuenoud, et al.. (2006). In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1 H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action. Journal of Pharmacology and Experimental Therapeutics. 317(2). 762–770. 128 indexed citations
17.
Dowling, Mark R., Jonathon M. Willets, David C. Budd, et al.. (2006). A Single Point Mutation (N514Y) in the Human M3 Muscarinic Acetylcholine Receptor Reveals Differences in the Properties of Antagonists: Evidence for Differential Inverse Agonism. Journal of Pharmacology and Experimental Therapeutics. 317(3). 1134–1142. 16 indexed citations
18.
Wiseman, Howard M., Andrew C. Doherty, & Mark R. Dowling. (2006). Entanglement of indistinguishable particles in condensed-matter physics (12 pages). Physical Review A. 73(5). 52323. 1 indexed citations
19.
Dowling, Mark R., P. D. Drummond, Matthew J. Davis, & Piotr Deuar. (2005). Time-Reversal Test for Stochastic Quantum Dynamics. Physical Review Letters. 94(13). 130401–130401. 15 indexed citations
20.
Dowling, Mark R., Stefan R. Nahorski, & R. A. John Challiss. (2004). Measurement of Agonist-Stimulated [<SUP>35</SUP>S]GTPγS Binding to Assess Total G-Protein and Gα-Subtype-Specific Activation by G-Protein-Coupled Receptors. Humana Press eBooks. 259. 197–206. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominic J. Williamson Breakdown of academic impact, for papers by Makoto Katori Breakdown of academic impact, for papers by Charles K. Kaufman Breakdown of academic impact, for papers by Shoudan Liang Breakdown of academic impact, for papers by Anil Kumar Breakdown of academic impact, for papers by Gyan Bhanot Breakdown of academic impact, for papers by A. S. Majumdar Breakdown of academic impact, for papers by Stephen A. Ramsey Breakdown of academic impact, for papers by David C. Torney Breakdown of academic impact, for papers by Иван Тодоров
Rankless by CCL
2026